Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2019

01-07-2019 | Liver Transplantation | Editorial

Biliary Strictures After Liver Transplantation with Grafts from Donors After Cardiac Death: Narrowing Down the Etiologies

Authors: Hamzeh Saraireh, Latha Thankam Sundaram, Binu V. John

Published in: Digestive Diseases and Sciences | Issue 7/2019

Login to get access

Excerpt

Liver transplantation (LT) is the standard-of-care for patients with end-stage liver disease. With improving techniques, graft and patient outcomes are excellent. The number of orthotopic LTs in the USA is on the rise; since demand for livers continues to exceed supply, transplant centers are constantly expanding donor liver utilization criteria [1]. Traditionally, allografts that are obtained through donation after brain death (DBD) have been the principal source of liver allograft donor pool. Donation after cardiac death (DCD) is on the rise in the USA and is becoming a rapidly growing source of liver allografts to fill the gap in organ scarcity. Unlike DBD grafts, livers from DCD suffer from a variable form of ischemia. Hence, DCD allografts are at a higher risk of developing biliary complications (biliary strictures and ischemic cholangiopathy), with resultant graft loss and death [2]. An analysis of the national registry of LT recipients database showed that DCD allografts experienced inferior survival at 1 and 3 years as well as a higher risk of re-transplantation compared to DBD recipients [3]. Similar results were reported in a prospective multicenter study in the UK [4]. Despite recent advances in treatments for biliary strictures after LT, they continue to be of concern as they are observed in approximately in 5–15% of patients following deceased donor LT and 28–32% following living donor LTs [5]. …
Literature
1.
go back to reference Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2016 annual data report: liver. Am J Transplant.. 2018;18:172–253.CrossRefPubMed Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2016 annual data report: liver. Am J Transplant.. 2018;18:172–253.CrossRefPubMed
2.
go back to reference O’Neill S, Roebuck A, Khoo E, Wigmore SJ, Harrison EM. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014;27:1159–1174.CrossRefPubMed O’Neill S, Roebuck A, Khoo E, Wigmore SJ, Harrison EM. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014;27:1159–1174.CrossRefPubMed
3.
go back to reference Jay C, Ladner D, Wang E, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant—an analysis of the national registry. J Hepatol. 2011;55:808–813.CrossRefPubMedPubMedCentral Jay C, Ladner D, Wang E, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant—an analysis of the national registry. J Hepatol. 2011;55:808–813.CrossRefPubMedPubMedCentral
4.
go back to reference Callaghan CJ, Charman SC, Muiesan P, et al. Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open. 2013;3:e003287.CrossRefPubMedPubMedCentral Callaghan CJ, Charman SC, Muiesan P, et al. Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open. 2013;3:e003287.CrossRefPubMedPubMedCentral
6.
go back to reference Sharma S, Gurakar A, Jabbour N. Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl. 2008;14:759–769.CrossRefPubMed Sharma S, Gurakar A, Jabbour N. Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl. 2008;14:759–769.CrossRefPubMed
7.
8.
go back to reference Forrest EA, Reiling J, Lipka G, Fawcett J. Risk factors and clinical indicators for the development of biliary strictures post liver transplant: significance of bilirubin. World J Transplant. 2017;7:349–358.CrossRefPubMedPubMedCentral Forrest EA, Reiling J, Lipka G, Fawcett J. Risk factors and clinical indicators for the development of biliary strictures post liver transplant: significance of bilirubin. World J Transplant. 2017;7:349–358.CrossRefPubMedPubMedCentral
10.
go back to reference Hong JC, Yersiz H, Kositamongkol P, et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg. 2011;146:1017–1023.CrossRefPubMed Hong JC, Yersiz H, Kositamongkol P, et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg. 2011;146:1017–1023.CrossRefPubMed
11.
go back to reference Mocchegiani F, Vincenzi P, Lanari J, et al. Immunological risk factors in biliary strictures after liver transplantation. Ann Transplant. 2015;20:218–224.CrossRefPubMed Mocchegiani F, Vincenzi P, Lanari J, et al. Immunological risk factors in biliary strictures after liver transplantation. Ann Transplant. 2015;20:218–224.CrossRefPubMed
12.
go back to reference Jayant K, Reccia I, Virdis F, Shapiro AMJ. The role of normothermic perfusion in liver transplantation (TRaNsIT Study): a systematic review of preliminary studies. HPB Surg. 2018;2018:6360423.CrossRefPubMedPubMedCentral Jayant K, Reccia I, Virdis F, Shapiro AMJ. The role of normothermic perfusion in liver transplantation (TRaNsIT Study): a systematic review of preliminary studies. HPB Surg. 2018;2018:6360423.CrossRefPubMedPubMedCentral
Metadata
Title
Biliary Strictures After Liver Transplantation with Grafts from Donors After Cardiac Death: Narrowing Down the Etiologies
Authors
Hamzeh Saraireh
Latha Thankam Sundaram
Binu V. John
Publication date
01-07-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05589-4

Other articles of this Issue 7/2019

Digestive Diseases and Sciences 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.